Blood Viscometer Market Size, Share & Industry Analysis, By Technology (Rotational Viscometer, Capillary Viscometer, Vibrational/Oscillatory Viscometer, and Others), By Application (Clinical Diagnostics & Patient Monitoring and Research), By End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

The global blood viscometer market size was valued at USD 1.68 billion in 2025. The market is projected to grow from USD 1.77 billion in 2026 to USD 2.67 billion by 2034, exhibiting a CAGR of 5.2% during the forecast period.

Blood viscometers are devices used to measure the thickness and flow properties of blood in diseases such as diabetes, cardiovascular disorders, stroke, and inflammatory conditions. The market growth is attributed to the increasing use of these viscometers in hospitals, diagnostic laboratories, and research centers due to the higher incidence of cardiovascular diseases, diabetes cases, and an aging population worldwide.

Furthermore, RheoSense, Inc., AMETEK.Inc., and A&D Company, Limited held the majority of the market share in 2025 due to their strong global presence and high precision instruments.

BLOOD VISCOMETER MARKET TRENDS

Shift toward Automated and Digital Systems to Emerge as a Key Trend

Currently, there is a growing shift from manual viscometers to automated, digital systems. Modern devices deliver faster results, greater precision, and integration with laboratory information systems. As a result, companies are focusing on compact, user-friendly designs. Moreover, the use of microfluidic technology, requiring smaller blood samples and providing quick results, is increasing.

• For instance, in February 2026, Anton Paar launched ViscoQC, an automated rotational viscometer engineered for streamlined routine viscosity testing via intuitive guided controls.

Download Free sample to learn more about this report.

MARKET DYNAMICS

MARKET DRIVERS

Rising Burden of Cardiovascular and Metabolic Diseases to Fuel the Market Expansion

Over the past few years, there have been increasing cases of heart diseases, diabetes, and blood-related disorders and blood viscosity is closely linked with hypertension, stroke risk, and vascular complications. As a result, physicians are increasingly using viscosity testing as part of patient monitoring in high-risk groups, thereby driving the product demand. Such a scenario is anticipated to drive the global blood viscometer market growth.

• For instance, in September 2025, the World Health Organization (WHO) reported that approximately 1.4 billion adults aged 30-79 globally had hypertension as of 2024.

MARKET RESTRAINTS

High Cost of Advanced Devices to Restrict Market Growth

Despite significant adoption, fully automated digital systems are expensive and may not be affordable for small laboratories or healthcare centers in developing regions. In addition to the device cost, maintenance and calibration expenses add to the overall burden. Further, some hospitals still rely on conventional laboratory tests rather than specialized viscosity testing due to budget constraints. Moreover, the lack of skilled professionals to operate advanced rheology equipment is also expected to limit adoption, hindering the market growth.

• For instance, in February 2025, LabX noted that new viscometers and rheometers typically cost between USD 2,000 and USD 50,000, depending on type, precision, and included features.

MARKET OPPORTUNITIES

Growth in Research and Development to Offer Significant Opportunities

In recent years, blood viscosity has been increasingly studied to understand inflammation, cancer progression, and microcirculation disorders. As a result, pharmaceutical companies and research institutes are investing in hemorheology studies to improve drug development. 

This is expected to offer lucrative opportunities for key players to collaborate with research institutions and pharmaceutical companies to develop microfluidic viscometers for advanced blood flow studies, thereby supporting market expansion.

MARKET CHALLENGES 

Limited Clinical Standardization to Challenge Market Expansion

Despite the significant importance of blood viscosity in many diseases, it is not yet considered a standard test in all hospitals. Furthermore, different laboratories use different measurement methods, leading to variations in results. This lack of uniform standards is anticipated to limit widespread clinical adoption.

Moreover, regulatory approval processes for new devices are lengthy and complex, pushing manufacturers to invest in clinical validation studies to demonstrate the benefits of routine viscosity testing. This is expected further to increase time and cost, challenging market expansion.

Segmentation Analysis

By Technology

Widespread Usage of Capillary Viscometers across Clinical Laboratories to Boost the Segment’s Growth

Based on technology, the market is segmented into rotational viscometer, capillary viscometer, vibrational/oscillatory viscometer, and others.

To know how our report can help streamline your business, Speak to Analyst

The capillary viscometer segment accounted for the largest global blood viscometer market share in 2025. Capillary viscometers are simple, reliable, and cost-effective, which is driving their adoption across clinical laboratories and hospitals for routine testing and research applications, thereby contributing to the segment’s expansion.

Additionally, the rotational viscometer segment is projected to grow at a CAGR of 4.7% during the forecast period. 

By Application 

Increasing Hospital Admissions to Drive Clinical Diagnostics & Patient Monitoring Segment Growth

By application, the market is segmented into clinical diagnostics & patient monitoring and research.

The clinical diagnostics & patient monitoring segment accounted for the largest market share in 2025. The segment's growth is driven by increasing hospital admissions for chronic diseases, which are driving the demand for blood viscosity testing to help doctors assess cardiovascular risk, monitor diabetes patients, and evaluate inflammatory diseases. The segment is estimated to hold a 72.0% share in 2026. 

Additionally, the research segment is anticipated to grow at a CAGR of 4.9% over the forecast period.

By End-user

Rising Number of Hospitals Worldwide to Drive the Hospitals & Diagnostic Laboratories Segment’s Growth

On the basis of end-user, the market is segmented into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, and others.

In 2025, the hospitals & diagnostic laboratories segment dominated the market in terms of end user. The segment growth is attributed to higher testing volume in these settings, which are equipped with better resources and skilled staff to operate viscometers. Moreover, the increasing number of hospitals is also anticipated to support this demand. Furthermore, the segment is set to hold a 50.1% share in 2026. 

• For instance, according to the American Hospital Association, the U.S. has around 6,100 registered hospitals as of 2026.

In addition, the academic & research institutes segment is projected to grow at a CAGR of 5.0% over the forecast period. 

Blood Viscometer Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America

North America accounted for the largest share of revenues in 2024, valued at USD 0.65 billion, and also held the largest share in 2025, reaching a value of USD 0.69 billion. The growth is attributed to the well-established network of clinical laboratories, which is expected to favor the adoption of viscometers in the region.

To get more information on the regional analysis of this market, Download Free sample

• For instance, according to data from Laboratory of Florida LLC., in February 2026, over 200,000 clinical laboratories provided testing services in the U.S.

U.S. Blood Viscometer Market

In 2026, the U.S. is projected to reach USD 0.62 billion, accounting for approximately 35.0% of the global market.

Europe

The Europe market is projected to record a 5.2% growth rate during the projection period, the second-highest globally, reaching USD 0.50 billion by 2026. European research institutions are actively studying blood rheology in stroke and vascular diseases, which is influencing key players to expand their product offerings in the region.

U.K. Blood Viscometer Market 

The U.K. market is expected to reach USD 0.11 billion by 2026, accounting for roughly 5.9% of global revenues. 

Germany Blood Viscometer Market 

The Germany market is projected to reach USD 0.12 billion by 2026, accounting for approximately 6.5% of global revenue. 

Asia Pacific 

By 2026, the Asia Pacific market is expected to reach USD 0.38 billion, ranking third globally. Governments in the region are investing in hospital upgrades and laboratory automation, which is expected to fuel product demand, driving market growth.

Japan Blood Viscometer Market 

The Japan market is projected to generate USD 0.10 billion in revenue by 2026, accounting for approximately 5.8% of the global market. 

China Blood Viscometer Market

The China market is expected to reach nearly USD 0.13 billion by 2026, accounting for 7.5% of global revenues.

India Blood Viscometer Market

The India market is projected to reach USD 0.04 billion by 2026, accounting for around 2.4% of global market revenue.

Latin America and Middle East & Africa

Both Latin America and the Middle East & Africa markets are expected to showcase moderate growth, with the Latin America market predicted to reach USD 0.10 billion by 2026. The growth of these regions is expected to be driven by rising healthcare investments and expanding private hospital networks, as well as increasing demand for viscometers.

GCC Blood Viscometer Market

By 2026, the GCC market is expected to reach USD 0.04 billion, accounting for 2.3% of total market revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Strong Brand Reputation and Diversified Portfolios to Strengthen the Market Position of Key Players

In 2025, RheoSense, Inc., AMETEK.Inc., and A&D Company, Limited held the majority of the global blood viscometer market share. The share is mainly due to their strong brand reputation, strong international presence, and high-precision instruments.

Moreover, other prominent players are collaborating with research institutions, focusing on product innovations, and expanding their geographical presence to capture a significant portion of the market.

LIST OF KEY BLOOD VISCOMETER COMPANIES PROFILED

• Benson Viscometers – Clinical Viscometers (U.K.)
• RheoSense, Inc. (U.S.)
• proRheo GmbH (Germany)
• A&D Company, Limited (Japan)
• AMETEK.Inc. (U.S.)
• TA Instruments (U.S.)
• Cole-Parmer Instrument Company, LLC. (U.S.)
• IKA (Germany)
• LAMY RHEOLOGY (France)
• Hydramotion Ltd. (U.K.)

KEY INDUSTRY DEVELOPMENTS

• November 2025: Benson Viscometers – Clinical Viscometers attended MEDICA 2025 in Düsseldorf, showcasing their clinical viscometers, including BV1 semi-automated clinical viscometer and BV200 automated clinical viscometer.
• September 2025: Benson Viscometers – Clinical Viscometers announced its participation in the IBMS Congress 2025 to showcase its clinical viscometers, improving its brand presence.
• July 2025: Biorheologics Co. Ltd. received a U.S. patent for a compact blood viscosity measurement kit that uses a disposable U-shaped capillary viscometer.
• January 2023: RheoSense, Inc. unveiled the m-VROC II, a next-generation high-precision viscometer that measures viscosity using 15 microliters of sample with 2% accuracy and 0.5% repeatability.
• June 2021: PERL researchers at TotalEnergies Lacq facility developed a low-cost, portable viscometer prototype for hospitals to measure blood viscosity using webcam-based flow detection in syringes.

REPORT COVERAGE 

The report presents a comprehensive analysis of all market segments, covering key drivers, trends, opportunities, restraints, and challenges shaping the market. It also includes insights into technological developments, recent industry activities, market share evaluation, and detailed company profiles of key players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation